ABACUS trial: preoperative atezolizumab in urothelial carcinoma

The ABACUS trial (NCT02662309), an investigator-initiated Phase II study investigating the safety and efficacy of two cycles of neoadjuvant atezolizumab in T2-T4a transitional cell carcinoma of the bl... Author: VJOncology Added: 08/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts